Créer une activité
Jouer Relier
1. The formal diagnosis of COPD is made with spirometry; when the ratio of forced expiratory volume in 1 second over forced vital capacity (FEV1/FVC) is less than 70% of that predicted for a matched control, it is diagnostic for a significant obstructive defect. Criteria for assessing the severity of airflow obstruction (based on the percent predicted postbronchodilator FEV1) are as follows:
2. Arterial blood gas (ABG) findings are as follows:
3. In patients with emphysema, frontal and lateral chest radiographs reveal the following:
4. Advantages of high-resolution CT include the following:
5. Other tests are as follows:

Pulse oximetry, combined with clinical observation, provides instant feedback on a patient's status

Chronic respiratory acidosis leads to compensatory metabolic alkalosis

Rapidly tapering vascular shadows accompanied by hyperlucency of the lungs

Electrocardiography can help establish that hypoxia is not resulting in cardiac ischemia and that the underlying cause of respiratory difficulty is not cardiac in nature

Sputum evaluation will show a transformation from mucoid in stable chronic bronchitis to purulent in acute exacerbations

A long, narrow heart shadow

As the disease progresses, hypoxemia worsens and hypercapnia may develop, with the latter commonly being observed as the FEV1 falls below 1 L/s or 30% of the predicted value

Greater sensitivity than standard chest radiography

pH usually is near normal; a pH below 7.3 generally indicates acute respiratory compromise

Increased retrosternal air space

Serum potassium – Diuretics, beta-adrenergic agonists, and theophylline act to lower potassium levels

ABGs provide the best clues as to acuteness and severity of disease exacerbation

Flattening of the diaphragm

Stage IV (very severe): FEV1 less than 30% of predicted or FEV1 less than 50% and chronic respiratory failure

Stage II (moderate): FEV1 50-79% of predicted

Radiographs in patients with chronic bronchitis show increased bronchovascular markings and cardiomegaly

Hematocrit – Patients with polycythemia (hematocrit greater than 52% in men or 47% in women) should be evaluated for hypoxemia at rest, with exertion, or during sleep

Patients with mild COPD have mild to moderate hypoxemia without hypercapnia

Stage III (severe): FEV1 30-49% of predicted

Measure AAT in all patients younger than 40 years, in those with a family history of emphysema at an early age, or with emphysematous changes in a nonsmoker (also see Alpha1-Antitrypsin Deficiency).

Stage I (mild): FEV1 80% or greater of predicted

May help the clinician determine whether surgical intervention would benefit the patient

May provide an adjunctive means of diagnosing various forms of COPD (eg, lower lobe disease may suggest alpha1-antitrypsin (AAT) deficiency

High specificity for diagnosing emphysema (outlined bullae are not always visible on a radiograph)